drugset / Trial / NCT05798403

Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder

NCT05798403

Recruiting 204 enrolled Yin Ping Longhua Hospital · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Through a scientific and standardized multicenter, blinding, double-dummy, randomized controlled, noninferiority clinical trial study method, the investigators evaluated electroacupuncture as a safe and effective non-pharmacological treatment for OAB in women by comparison with Solifenacin Succinate.

Timeline

Start
2023-07-07
Primary completion
2025-08-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Solifenacin Small molecule 5 mg Oral

Indications